Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Brain Neoplasms × alectinib × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 6 Lung Neoplasms 3 Neoplasms 2 Solid Tumors 1 Multiple Endocrine Neoplasia Type 2a 1 Lung Diseases 1 Central Nervous System Neoplasms 1 Carcinoma, Hepatocellular 1 Brain Neoplasms 1 Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer 1

Interventions

Radiosurgery 24 Magnetic Resonance Spectroscopy 19 Temozolomide 14 Specimen Handling 9 Radiotherapy 9 Cyclophosphamide 9 pembrolizumab 7 Bevacizumab 7 abemaciclib 6 trastuzumab deruxtecan 5 Nivolumab 5 Ipilimumab 5 Etoposide 5 Carboplatin 5 Radiation 4 Biopsy 4 fludarabine 3 entrectinib 3 X-Rays 3 Trastuzumab 3 Mental Status and Dementia Tests 3 Dexamethasone 3 Capecitabine 3 Blood Specimen Collection 3 niraparib 2 etoposide phosphate 2 cabozantinib 2 aflutinib 2 Topotecan 2 Surveys and Questionnaires 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05987644 2026-03-09

DURABLE

Hoosier Cancer Research Network

Phase 1/2 Recruiting

Brain Neoplasms, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡